Weight-based LMWH dosing without capping is OK for obese patients

Weight-based dosing of enoxaparin with no maximum dose appears to result in similar therapeutic drug levels in obese patients compared to non-obese patients with acute venous thromboembolism (VTE). A five-year retrospective study compared outcomes in patients >100 kg treated with 1 mg/kg enoxaparin twice daily, patients <100 kg on the same dosing schedule and patients ...

Already a member?

Login to keep reading.

© 2021 the limbic